Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02505230 · ClinicalTrials.gov registry record · NA

Meal Presentation and Liking

A NA study of Volume and Energy Density, sponsored by The University of Tennessee, Knoxville.

Active
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT02505230: Active NA study of Volume and Energy Density, sponsored by The University of Tennessee, Knoxville.

NCT02505230 is a NA study of Volume and Energy Density that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02505230, a NA study of Volume and Energy Density, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the energy consumed from an entree with high- or low-volume vegetables incorporated into the entree or served along side of the entree, in normal weight adults.

Interventions

  • BEHAVIORAL Eating

Study Locations (1)

Tennessee

  • Healthy Eating and Activity Laboratory, University of Tennessee - Knoxville

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2015-07
Est. Completion 2025-12-31
Phase NA

What the registry record for NCT02505230 still lists

NCT02505230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Volume appearing as the primary indexed condition, and to 1 intervention - of which Eating is the first listed.

NCT02505230 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT02505230 about?

NCT02505230 is a clinical study titled "Meal Presentation and Liking". This study will investigate the energy consumed from an entree with high- or low-volume vegetables incorporated into the entree or served along side of the entree, in normal weight adults.

What is the current status of trial NCT02505230?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2015-07. Estimated completion is 2025-12-31.

What conditions does trial NCT02505230 study?

This clinical trial studies the following conditions: Volume, Energy Density, Meal Presentation.

What interventions are being tested in trial NCT02505230?

The interventions under investigation include: Eating (BEHAVIORAL).

Who is sponsoring clinical trial NCT02505230?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02505230 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Volume

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02505230's enrollment target sits among peer trials

45 1411th of 2000 higher than 578 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02505230, the US trial registry maintained by the National Library of Medicine. NCT02505230 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.